Boston Globe: 'Knock out the middlemen' is a campaign promise Donald Trump should keep
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
‘Knock out the middlemen’: A campaign promise Donald Trump should keep
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
Opinion
Editorial Roundup: United States
Excerpts from recent editorials in the United States and abroad: ___ Jan. 26 The Washington Post on Trump's “energy emergency” Oil and gas production in the United States is hitting record highs, ...
The Associated Press on MSN14d
Newsom committed California to making its own insulin. It’s at least a year behind his schedule
the brand name insulin glargine, without needing a separate prescription. The length of time it takes for a company to develop a drug, get FDA approval and bring it to market is highly variable, said ...
Connecticut Post15d
Newsom committed California to making its own insulin. It’s at least a year behind his schedule
the brand name insulin glargine, without needing a separate prescription. The length of time it takes for a company to develop a drug, get FDA approval and bring it to market is highly variable ...